FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Cohen

Research Profile

Procedures

Devices

Stents

Concepts & Ideas

Activities & Behaviors

Cost Benefit Analysis

Disorders

Chemicals & Drugs

Geographic Areas

United States

Co-author Network

Publications

TOP 3
Matthew R Reynolds; Lowell E Satler; Craig R Smith; Lars G Svensson; Vinod H Thourani; Katherine Vilain; Joshua Walczak; Kaijun Wang; Joseph E Bavaria; David J Cohen; Yang Lei; Martin B Leon; Haiyan Li; Michael J Mack; Elizabeth A Magnuson; D Craig Miller; Duane S Pinto
Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A).
Ronald P Caputo; David J Cohen; Gaurav Dhar; Ankush Goel; Paul Gordon; Neal S Kleiman; Michael Pencina; Paul Tolerico; Ron Waksman; Chen-Hsing Yen; Richard G Bach; John J Lopez
Impact of drug eluting stent length on outcomes of percutaneous coronary intervention (from the EVENT registry).
Matthew R Reynolds; Peter Zimetbaum; Mark E Josephson; Ethan Ellis; Tatyana Danilov; David J Cohen
Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Cohen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Matthew R Reynolds; Lowell E Satler; Craig R Smith; Lars G Svensson; Vinod H Thourani; Katherine Vilain; Joshua Walczak; Kaijun Wang; Joseph E Bavaria; David J Cohen; Yang Lei; Martin B Leon; Haiyan Li; Michael J Mack; Elizabeth A Magnuson; D Craig Miller; Duane S Pinto
Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A).
Journal of the American College of Cardiology 2012;60(25):2683-92.
2012: Ronald P Caputo; David J Cohen; Gaurav Dhar; Ankush Goel; Paul Gordon; Neal S Kleiman; Michael Pencina; Paul Tolerico; Ron Waksman; Chen-Hsing Yen; Richard G Bach; John J Lopez
Impact of drug eluting stent length on outcomes of percutaneous coronary intervention (from the EVENT registry).
The American journal of cardiology 2012;110(3):350-5.
2009: Matthew R Reynolds; Peter Zimetbaum; Mark E Josephson; Ethan Ellis; Tatyana Danilov; David J Cohen
Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillation.
Circulation. Arrhythmia and electrophysiology 2009;2(4):362-9.
2009: Victor Novack; Donald E Cutlip; Neal Kleiman; Michael Pencina; Laura Mauri; Chen-Hsing Yen; Peter Berger; Steven Goldberg; Mirle Kellett; Ronald Waksman; Mun Hong; Albert E Raizner; David J Cohen
In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.
JACC. Cardiovascular interventions 2009;2(8):767-75.
2009: Victor Novack; Daniel Tsyvine; David J Cohen; Michael Pencina; Joseph Dubin; Hossein Dehghani; Neal S Kleiman; Donald E Cutlip
Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2009;73(7):874-80.
2008: Phillip P Brown; Aaron D Kugelmass; David J Cohen; Matthew R Reynolds; Steven D Culler; Ansley D Dee; April W Simon
The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program.
The Annals of thoracic surgery 2008;85(6):1980-6.
2008: Michael J Rinaldi; Ajay J Kirtane; Robert N Piana; Ronald P Caputo; Paul C Gordon; JJ Lopez; Harold L Dauerman; Thomas Ryan; Francis J Kiernan; Donald E Cutlip; Kalon K L Ho; C Michael Gibson; Sabina A Murphy; David J Cohen
Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events.
American heart journal 2008;155(4):654-60.
2007: Matthew R Reynolds; Duane S Pinto; Chunxue Shi; Joshua Walczak; Ronna H Berezin; David R Holmes; David J Cohen
Cost-effectiveness of sirolimus-eluting stents compared with vascular brachytherapy for the treatment of in-stent restenosis.
American heart journal 2007;154(6):1221-7.
2007: Ramon Kumar; Tobias T Lee; Allen Jeremias; Christopher P Ruisi; Brett Sylvia; Jorge Magallon; Ajay J Kirtane; Brian Bigelow; Martin Abrahamson; Duane S Pinto; Kalon K L Ho; David J Cohen; Joseph P Carrozza; Donald E Cutlip
Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients.
The American journal of cardiology 2007;100(8):1187-91.
2007: Matthew R Reynolds; Vidal Essebag; Peter Zimetbaum; David J Cohen
Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry.
Journal of cardiovascular electrophysiology 2007;18(6):628-33.
2007: Htut K Win; Angel E Caldera; Kelly Maresh; John Lopez; Charanjit S Rihal; Manish A Parikh; Juan F Granada; Sachin Marulkar; Deborah Nassif; David J Cohen; Neal S Kleiman
Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents.
JAMA : the journal of the American Medical Association 2007;297(18):2001-9.
2007: Adam Skolnick; Karen P Alexander; Anita Y Chen; Matthew T Roe; Charles V Pollack; Erik Ohman; John S Rumsfeld; W Brian Gibler; Eric D Peterson; David J Cohen
Characteristics, management, and outcomes of 5,557 patients age > or =90 years with acute coronary syndromes: results from the CRUSADE Initiative.
Journal of the American College of Cardiology 2007;49(17):1790-7.
2006: Matthew R Reynolds; Tara A Lavelle; Vidal Essebag; David J Cohen; Peter Zimetbaum
Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) study.
American heart journal 2006;152(6):1097-103.
2006: Duane S Pinto; Ajay J Kirtane; Brahmajee K Nallamothu; Sabina A Murphy; David J Cohen; Roger J Laham; Donald E Cutlip; Eric R Bates; Paul D Frederick; Dave P Miller; Joseph P Carrozza; Elliott M Antman; Christopher P Cannon; C Michael Gibson
Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy.
Circulation 2006;114(19):2019-25.
2006: Glenn N Levine; Peter B Berger; David J Cohen; Andrew O Maree; Kenneth Rosenfield; Barbara S Wiggins; Sarah A Spinler
Newer pharmacotherapy in patients undergoing percutaneous coronary interventions: a guide for pharmacists and other health care professionals.
Pharmacotherapy 2006;26(11):1537-56.
2006: Jason Ryan; David J Cohen
Are drug-eluting stents cost-effective? It depends on whom you ask.
Circulation 2006;114(16):1736-43; discussion 1744.
2006: C Michael Gibson; Ajay J Kirtane; David A Morrow; Theresa M Palabrica; Sabina A Murphy; Peter H Stone; Benjamin M Scirica; Lisa K Jennings; Howard C Herrmann; David J Cohen; Carolyn H McCabe; Eugene Braunwald
Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
American heart journal 2006;152(4):756-61.
2006: Tobias T Lee; Loryn Feinberg; Donald S Baim; David R Holmes; Julian M Aroesty; Joseph P Carrozza; David J Cohen; Kalon K L Ho; Donald E Cutlip
Effect of diabetes mellitus on five-year clinical outcomes after single-vessel coronary stenting (a pooled analysis of coronary stent clinical trials).
The American journal of cardiology 2006;98(6):718-21.
2006: Ameet Bakhai; Gregg W Stone; Elizabeth Mahoney; Tara A Lavelle; Chunxue Shi; Ronna H Berezin; Betsy J Lahue; maryann clark; Michael J Lacey; Mary E Russell; Stephen G Ellis; James Hermiller; David A Cox; David J Cohen
Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
Journal of the American College of Cardiology 2006;48(2):253-61.
2006: Matthew R Reynolds; David J Cohen; Aaron D Kugelmass; Phillip P Brown; Edmund R Becker; Steven D Culler; April W Simon
The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators.
Journal of the American College of Cardiology 2006;47(12):2493-7.
2006: Ajay J Kirtane; Gregory Piazza; Sabina A Murphy; Daniela Budiu; David A Morrow; David J Cohen; Eric Peterson; Nasser Lakkis; Howard C Herrmann; Theresa M Palabrica; C Michael Gibson
Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial.
Journal of the American College of Cardiology 2006;47(12):2374-9.
2006: C Michael Gibson; David A Morrow; Sabina A Murphy; Theresa M Palabrica; Lisa K Jennings; Peter H Stone; Henry H Lui; Thomas Bulle; Nasser Lakkis; Richard Kovach; David J Cohen; Polly Fish; Carolyn H McCabe; Eugene Braunwald
A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial.
Journal of the American College of Cardiology 2006;47(12):2364-73.
2006: C Michael Gibson; Dimitrios Karmpaliotis; Ioanna Kosmidou; Sabina A Murphy; Ajay J Kirtane; Daniela Budiu; Kausik K Ray; Howard C Herrmann; Nasser Lakkis; Richard Kovach; William J French; James Blankenship; Henry H Lui; Theresa M Palabrica; Lisa K Jennings; David J Cohen; David A Morrow
Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome.
The American journal of cardiology 2006;97(10):1473-7.
2006: Aaron D Kugelmass; David J Cohen; Phillip P Brown; April W Simon; Edmund R Becker; Steven D Culler
Hospital resources consumed in treating complications associated with percutaneous coronary interventions.
The American journal of cardiology 2006;97(3):322-7.
2006: Ameet Bakhai; David J Cohen
Economic implications of bivalirudin in the cardiac catheterization laboratory.
Reviews in cardiovascular medicine 2006;7 Suppl 3():S35-42.
2006: Stéphane Rinfret; David J Cohen; Amir A Tahami Monfared; Jacques LeLorier; Jean Mireault; Erick Schampaert
Cost effectiveness of the sirolimus-eluting stent in high-risk patients in Canada: an analysis from the C-SIRIUS trial.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2006;6(3):159-68.
2006: Tobias T Lee; Jersey Chen; David J Cohen; Lana Tsao
The association between blood pressure and mortality in patients with heart failure.
American heart journal 2006;151(1):76-83.
2005: Jason W Ryan; Eric D Peterson; Anita Y Chen; Matthew T Roe; Erik Ohman; Christopher P Cannon; Peter B Berger; Jorge F Saucedo; Elizabeth R DeLong; Sharon-Lise T Normand; Charles V Pollack; David J Cohen
Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Registry.
Circulation 2005;112(20):3049-57.
2005: Sonia Jacob; David J Cohen; Joseph Massaro; Paulette Niemyski; Kelly Maresh; Neal S Kleiman
Design of a registry to characterize "real-world" outcomes of percutaneous coronary revascularization in the drug-eluting stent era.
American heart journal 2005;150(5):887-92.
2005: Warren J Cantor; Mina Madan; J Conor O'Shea; Robert J Chisholm; Henry K Lui; David J Cohen; Robert L Feldman; Robert Green; Anne S Hellkamp; Michael M Kitt; James E Tcheng
Bailout use of platelet glycoprotein IIb-IIIa inhibition during coronary stent implantation: observations from the ESPRIT trial.
The Journal of invasive cardiology 2005;17(7):360-4.
2005: maryann clark; Ameet Bakhai; Elise M Pelletier; David J Cohen
Clinical and economic effects of coronary restenosis after percutaneous coronary intervention in a managed care population.
Managed care (Langhorne, Pa.) 2005;14(4):42-4, 46-51.
2005: Stéphane Rinfret; David J Cohen; Gervasio A Lamas; Kirsten E Fleischmann; Milton C Weinstein; John Orav; Eleanor Schron; Kerry L Lee; Lee Goldman
Cost-effectiveness of dual-chamber pacing compared with ventricular pacing for sinus node dysfunction.
Circulation 2005;111(2):165-72.
2004: David J Cohen; Sabina A Murphy; Donald S Baim; Tara A Lavelle; Ronna H Berezin; Donald E Cutlip; Kalon K L Ho; Richard E Kuntz
Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial.
Journal of the American College of Cardiology 2004;44(9):1801-8.
2004: David J Cohen; A Michael Lincoff; Tara A Lavelle; Huei-Ling Chen; Ameet Bakhai; Ronna H Berezin; Daniel Jackman; Ian J Sarembock; Eric J Topol
Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial.
Journal of the American College of Cardiology 2004;44(9):1792-800.
2004: Dan Greenberg; Ameet Bakhai; Peter J Neumann; David J Cohen
Willingness to pay for avoiding coronary restenosis and repeat revascularization: results from a contingent valuation study.
Health policy (Amsterdam, Netherlands) 2004;70(2):207-16.
2004: Dan Greenberg; Kenneth Rosenfield; Lawrence A Garcia; Ronna H Berezin; Tara A Lavelle; Stanley Fogleman; David J Cohen
In-hospital costs of self-expanding nitinol stent implantation versus balloon angioplasty in the femoropopliteal artery (the VascuCoil Trial).
Journal of vascular and interventional radiology : JVIR 2004;15(10):1065-9.
2004: Allen Jeremias; Donald S Baim; Kalon K L Ho; Manish Chauhan; Joseph P Carrozza; David J Cohen; Jeffrey J Popma; Richard E Kuntz; Donald E Cutlip
Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures.
Journal of the American College of Cardiology 2004;44(6):1210-4.
2004: Donald E Cutlip; Amit G Chhabra; Donald S Baim; Manish S Chauhan; Sachin Marulkar; Joseph M Massaro; Ameet Bakhai; David J Cohen; Richard E Kuntz; Kalon K L Ho
Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials.
Circulation 2004;110(10):1226-30.
2004: David J Cohen; Ameet Bakhai; Chunxue Shi; Louise Githiora; Tara A Lavelle; Ronna H Berezin; Martin B Leon; Jeffrey W Moses; Joseph P Carrozza; James P Zidar; Richard E Kuntz
Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.
Circulation 2004;110(5):508-14.
2004: maryann clark; Ameet Bakhai; Michael J Lacey; Elise M Pelletier; David J Cohen
Clinical and economic outcomes of percutaneous coronary interventions in the elderly: an analysis of medicare claims data.
Circulation 2004;110(3):259-64.
2004: Allen Jeremias; Brett Sylvia; Jonathan Bridges; Ajay J Kirtane; Brian Bigelow; Duane S Pinto; Kalon K L Ho; David J Cohen; Lawrence A Garcia; Donald E Cutlip; Joseph P Carrozza
Stent thrombosis after successful sirolimus-eluting stent implantation.
Circulation 2004;109(16):1930-2.
2004: Dan Greenberg; Ameet Bakhai; David J Cohen
Can we afford to eliminate restenosis? Can we afford not to?
Journal of the American College of Cardiology 2004;43(4):513-8.
2003: Ameet Bakhai; Gregg W Stone; Cindy L Grines; Sabina A Murphy; Louise Githiora; Ronna H Berezin; David A Cox; Thomas D Stuckey; John J Griffin; James E Tcheng; David J Cohen
Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction: results from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial.
Circulation 2003;108(23):2857-63.
2003: Aaron D Kugelmass; David J Cohen; Frank Houser; Michael Mack; April W Simon; Salvatore L Battaglia; Lynn G Tarkington; Edmund R Becker; Steven D Culler
The influence of diabetes mellitus on the practice and outcomes of percutaneous coronary intervention in the community: a report from the HCA database.
The Journal of invasive cardiology 2003;15(10):568-74.
2003: Peter Zimetbaum; Matthew R Reynolds; Kalon K L Ho; Thomas Gaziano; Mary Jane McDonald; Seth McClennen; Ronna H Berezin; Mark E Josephson; David J Cohen
Impact of a practice guideline for patients with atrial fibrillation on medical resource utilization and costs.
The American journal of cardiology 2003;92(6):677-81.
2003: Deborah A Taira; Todd B Seto; Richard Siegrist; Roberta S Cosgrove; Ronna H Berezin; David J Cohen
Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials.
American heart journal 2003;145(3):452-8.
2003: David J Cohen; Frank Houser; Michael Mack; April W Simon; Salvatore L Battaglia; Lynn G Tarkington; Edmund R Becker; Steven D Culler
Practice and outcomes of percutaneous coronary intervention in the community before drug-eluting stents: a report from the HCA database.
The Journal of invasive cardiology 2003;15(3):121-7.
2003: Matthew R Reynolds; Nancy Neil; Kalon K L Ho; Ronna H Berezin; Roberta S Cosgrove; Robert A Lager; Cheryl Sirois; Robert G Johnson; David J Cohen
Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience.
American heart journal 2003;145(2):334-42.
2003: Duane S Pinto; Robert T Sperling; Thomas M Tu; David J Cohen; Joseph P Carrozza
Combination platelet glycoprotein IIb/IIIa receptor and lepirudin administration during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2003;58(1):65-8.
2002: Donald E Cutlip; Manish S Chauhan; Donald S Baim; Kalon K L Ho; Jeffrey J Popma; Joseph P Carrozza; David J Cohen; Richard E Kuntz
Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials.
Journal of the American College of Cardiology 2002;40(12):2082-9.
2002: Stéphane Rinfret; Peter T Katsiyiannis; Kalon K L Ho; David J Cohen; Donald S Baim; Joseph P Carrozza; Roger J Laham
Effectiveness of rheolytic coronary thrombectomy with the AngioJet catheter.
The American journal of cardiology 2002;90(5):470-6.
2002: Stéphane Rinfret; Donald E Cutlip; Peter T Katsiyiannis; Kalon K L Ho; David J Cohen; Joseph P Carrozza; Roger J Laham
Rheolytic thrombectomy and platelet glycoprotein IIb/IIIa blockade for stent thrombosis.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2002;57(1):24-30.
2002: David J Cohen; Roberta S Cosgrove; Ronna H Berezin; Paul S Teirstein; Martin B Leon; Richard E Kuntz
Cost-effectiveness of gamma radiation for treatment of in-stent restenosis: results from the Gamma-1 trial.
Circulation 2002;106(6):691-7.
2002: Matthew R Reynolds; Michael J Rinaldi; Duane S Pinto; David J Cohen
Current clinical characteristics and economic impact of subacute stent thrombosis.
The Journal of invasive cardiology 2002;14(7):364-8.
2002: Dan Greenberg; David J Cohen
Examining the economic impact of restenosis: implications for the cost-effectiveness of an antiproliferative stent.
Zeitschrift für Kardiologie 2002;91 Suppl 3():137-43.
2002: David J Cohen; J Conor O'Shea; Cindy M Pacchiana; Glenn Levine; Ian J Sarembock; James Slater; Eric Conn; Jack Smith; James E Tcheng
In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin.
The American journal of cardiology 2002;89(1):61-4.
2002: C Michael Gibson; Sabina A Murphy; Susan J Marble; David J Cohen; Eric A Cohen; Henry K Lui; Jeffrey Young; Michael M Kitt; Todd J Lorenz; James E Tcheng
Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement: an ESPRIT substudy.
American heart journal 2002;143(1):106-10.
2001: David J Cohen; Deborah A Taira; Ronna H Berezin; David A Cox; M C Morice; Gregg W Stone; Cindy L Grines
Cost-effectiveness of coronary stenting in acute myocardial infarction: results from the stent primary angioplasty in myocardial infarction (stent-PAMI) trial.
Circulation 2001;104(25):3039-45.
2001: David J Cohen; Stephen R Ramee; Donald S Baim; S Sharma; Joseph P Carrozza; Roberta S Cosgrove; N Jones; Ronna H Berezin; Donald E Cutlip; Kalon K L Ho; Richard E Kuntz
Economic assessment of rheolytic thrombectomy versus intracoronary urokinase for treatment of extensive intracoronary thrombus: Results from a randomized clinical trial.
American heart journal 2001;142(4):648-56.
2001: James C Blankenship; G Tasissa; J Conor O'Shea; Elias A Iliadis; F A Bachour; David J Cohen; Henry K Lui; Tift Mann; E Cohen; James E Tcheng
Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial.
Journal of the American College of Cardiology 2001;38(3):653-8.
2001: C Michael Gibson; David J Cohen; Eric A Cohen; Henry K Lui; Sabina A Murphy; Susan J Marble; Michael M Kitt; Todd J Lorenz; James E Tcheng
Effect of eptifibatide on coronary flow reserve following coronary stent implantation (an ESPRIT substudy). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy.
The American journal of cardiology 2001;87(11):1293-5.
2001: M S Chauhan; Richard E Kuntz; K L Ho; David J Cohen; Jeffrey J Popma; Joseph P Carrozza; Donald S Baim; Donald E Cutlip
Coronary artery stenting in the aged.
Journal of the American College of Cardiology 2001;37(3):856-62.
2000: Peter Zimetbaum; Mark E Josephson; M J McDonald; Seth McClennen; V Korley; Kalon K L Ho; Panos Papageorgiou; David J Cohen
Incidence and predictors of myocardial infarction among patients with atrial fibrillation.
Journal of the American College of Cardiology 2000;36(4):1223-7.
2000: Deborah A Taira; Todd B Seto; Kalon K L Ho; Harlan Krumholz; Donald E Cutlip; Ronna H Berezin; Richard E Kuntz; David J Cohen
Impact of smoking on health-related quality of life after percutaneous coronary revascularization.
Circulation 2000;102(12):1369-74.
2000: David J Cohen; Edmund R Becker; Steven D Culler; S Ellis; L M Green; R N Schnitzler; April W Simon; W S Weintraub
Impact of patient characteristics, complications, and facility volume on the costs and time of cardiac catheterization and coronary angioplasty in 70 catheterization laboratories.
The American journal of cardiology 2000;86(6):595-601.
2000: Rabih R Azar; R Prpic; Kalon K L Ho; Francis J Kiernan; Samuel J Shubrooks; Donald S Baim; J J Popma; Richard E Kuntz; David J Cohen
Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting.
The American journal of cardiology 2000;86(5):485-9.
2000: Harold L Dauerman; Duane S Pinto; K K Ho; C M Gibson; Richard E Kuntz; David J Cohen; Donald S Baim; Joseph P Carrozza
Outcome of patients with acute myocardial infarction who are ineligible for primary angioplasty trials.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2000;49(3):237-43.
1999: Joseph P Carrozza; S E Hosley; David J Cohen; Donald S Baim
In vivo assessment of stent expansion and recoil in normal porcine coronary arteries: differential outcome by stent design.
Circulation 1999;100(7):756-60.
1999: David J Cohen
Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Evaluation of the cost-effectiveness of coronary stenting: a societal perspective.
American heart journal 1999;137(5):S133-7.
1999: Peter Zimetbaum; V E Schreckengost; David J Cohen; R Lemery; D Love; L M Epstein; Roger J Laham; Mark E Josephson
Evaluation of outpatient initiation of antiarrhythmic drug therapy in patients reverting to sinus rhythm after an episode of atrial fibrillation.
The American journal of cardiology 1999;83(3):450-2, A9.
1998: Harold L Dauerman; P J Higgins; A M Sparano; C M Gibson; G R Garber; Joseph P Carrozza; Richard E Kuntz; R J Laham; Samuel J Shubrooks; Donald S Baim; David J Cohen
Mechanical debulking versus balloon angioplasty for the treatment of true bifurcation lesions.
Journal of the American College of Cardiology 1998;32(7):1845-52.
1998: Harold L Dauerman; Donald S Baim; D E Cutlip; A M Sparano; C M Gibson; Richard E Kuntz; Joseph P Carrozza; G R Garber; David J Cohen
Mechanical debulking versus balloon angioplasty for the treatment of diffuse in-stent restenosis.
The American journal of cardiology 1998;82(3):277-84.
1998: Harold L Dauerman; David J Cohen; Joseph P Carrozza; Richard E Kuntz; Donald S Baim
Rotational atherectomy for the treatment of restenotic ostial side branches jailed by prior stent placement.
Catheterization and cardiovascular diagnosis 1998;43(4):447-50.